Rapid Therapeutic ( OTCMKTS: RTSL ) Recent News
Rapid Therapeutic Science Laboratories, Inc. ( OTCMKTS: RTSL ) announced today that it has delivered an initial 2,000 units under its previously announced 100,000 unit order. Rapid Therapeutic Science Laboratories, Inc. Chairman and CEO, Donal R. Schmidt, Jr. stated,
RTSL is moving forward on its first major wholesale contract. We have completed the first shipment totaling 2,000 units of our proprietary CBD/CBG formula under our white label order of 100,000 units we previously announced. These MDIs are currently being sold through doctors’ offices and in pharmacies across the United States. The initial lot of 2,000 was presold by our customer before we manufactured them. We will continue to manufacture and ship under this order as we discuss additional white label opportunities with other distributors. This first shipment demonstrates our ability to deliver large unit orders on a timely basis while preserving product quality.
Additional News out this am from Financial News Media
According to The Journal Of Cannabinoid Medicine: “One of these so-called minor cannabinoids is cannabigerol (CBG), which is gaining attention for its proclaimed anti-bacterial, anti-microbial, and anti-inflammatory properties. While CBG has yet to match the mainstream appeal of CBD, this cannabinoid may soon play a starring role in everyday consumer products as it quietly demonstrates a wide array of highly intriguing medicinal benefits.”
The pharmacological effects of CBG described in the scientific literature include: anti-fungal, anti-insect and anti-inflammatory activity; neuroprotective activity; stimulation of appetite and enhancement of the death process of cancer cell. Dr. Itzhak Kurek, CEO and co-founder of a Northern California biotech company that uses bioinformatics (a combination of biology, Computer science, and mathematics, among other scientific disciplines) to improve medical cannabis… over the last few decades, scientists have left a paper trail of research that shows just how fruitful this relatively unknown cannabinoid could be.
Rapid Therapeutic ( OTCMKTS: RTSL ) Recent Short Squeeze
Over the past twenty days of trading, Rapid Therapeutic Science Laboratories, Inc. ( OTCMKTS: RTSL ), from March 25, 2020 to June 29, 2020 there is a potential Short Squeeze about to happen because of an increase in short volume over the past twenty days with very little cover volume.
Because of this the Squeeze Report trend indicator issued a Rapid Therapeutic Short Squeeze.
Rapid Therapeutic ( OTCMKTS: RTSL ) Chart
Rapid Therapeutic ( OTCMKTS: RTSL ) is listed on the Market Wire News Trending Stocks along with NASDAQ:AIHS, NASDAQ:NGHC, and NASDAQ:XENT to name a few. Be sure to check out our other cannabis or market articles.